Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab | BMC Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 31 Mar 2022